Back to Search Start Over

"Recovery Of Perfusion Bleed Product Via Alternating Tangential Flow Filtration In A Sedimentation Reactor" in Patent Application Approval Process (USPTO 20230383241).

Source :
Pharma Business Week; 12/18/2023, p428-428, 1p
Publication Year :
2023

Abstract

A patent application by inventors from Repligen Corporation has been made available online. The patent application describes a system and method for harvesting a product of interest from a bleed material in a perfusion bioreactor. The system includes a bioreactor, cell retention devices, harvest pumps, and a bleed recovery system. The invention aims to recover the product of interest from the bleed material without altering the culture environment. The patent application provides detailed descriptions of the components and operations of the system. [Extracted from the article]

Details

Language :
English
ISSN :
15436675
Database :
Complementary Index
Journal :
Pharma Business Week
Publication Type :
Periodical
Accession number :
174251586